China Regenerative Medicine International Limited (HKG:8158)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.3000
-0.0200 (-6.25%)
Apr 2, 2026, 3:16 PM HKT

HKG:8158 Cash Flow Statement

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
17.75-107.74.5651.83
Depreciation & Amortization
10.9611.325.390.08
Loss (Gain) From Sale of Assets
---38.49
Stock-Based Compensation
---2.16
Provision & Write-off of Bad Debts
----41.35
Other Operating Activities
-11.4683.9710.999.91
Change in Accounts Receivable
0.57-1.130.14-0.13
Change in Inventory
0.21-0.160.10.06
Change in Accounts Payable
1.372.42-0.03-8.14
Change in Unearned Revenue
-13.8920.35-9.3772.59
Change in Other Net Operating Assets
12.791.72-24.21-90.02
Operating Cash Flow
18.310.79-12.43-3.02
Operating Cash Flow Growth
69.65%---
Capital Expenditures
-0.63-0.27-2.59-0.81
Divestitures
---10.07
Other Investing Activities
0.010.0100.01
Investing Cash Flow
-0.62-0.26-2.599.27
Long-Term Debt Issued
21.187.0920.199.66
Total Debt Issued
21.187.0920.199.66
Long-Term Debt Repaid
-18.33-14.45-12.86-10.87
Total Debt Repaid
-18.33-14.45-12.86-10.87
Net Debt Issued (Repaid)
2.85-7.367.32-1.22
Other Financing Activities
-0.49-0.98--0.17
Financing Cash Flow
2.37-8.347.32-1.39
Foreign Exchange Rate Adjustments
-0.68-0.7-0.380.3
Net Cash Flow
19.371.49-8.085.16
Free Cash Flow
17.6810.52-15.03-3.83
Free Cash Flow Growth
68.11%---
Free Cash Flow Margin
19.51%15.13%-36.17%-1.35%
Free Cash Flow Per Share
0.060.04-0.05-0.01
Cash Interest Paid
0.490.980.780.74
Levered Free Cash Flow
69.98100.04-0.75-122.4
Unlevered Free Cash Flow
70.69100.65-0.26-121.94
Change in Working Capital
1.0623.2-33.37-25.65
Source: S&P Global Market Intelligence. Standard template. Financial Sources.